Rutgers Cancer Institute of New Jersey competitors

Zippia score 4.3

Competitor Summary. See how Rutgers Cancer Institute of New Jersey compares to its main competitors:

Sandia National Labs has the most employees (8,150).
The oldest company is Roswell Park, founded in 1898.

Work at Rutgers Cancer Institute of New Jersey?

Share your experience

Rutgers Cancer Institute of New Jersey vs competitors

Company	Founding date	Zippia score	Headquarters	# of Locations	Revenue	Employees
Rutgers Cancer Institute of New Jersey	1991	4.3	New Brunswick, NJ	1	$10.0M	50
Instituto Nacional De Salud Mental	1982	4.2	-	-	$13.0M	96
Roswell Park	1898	4.6	Buffalo, NY	2	$1.4B	3,064
Sandia National Labs	1948	4.6	Albuquerque, NM	2	$3.6B	8,150
JMI Laboratories	2000	4.2	North Liberty, IA	1	$18.0M	73
IIT	1986	3.4	Indianapolis, IN	1	$360,000	5
Mathematical Sciences Research Institute - MSRI	1982	4.3	Berkeley, CA	1	$15.6M	18
New York State Education Department	1904	4.3	Albany, NY	1	$213.7M	13
NCWIT	2004	4.1	Boulder, CO	1	$2.6M	15
One Laptop per Child	2005	4.0	Miami, FL	1	$3.5M	46
Pennington Biomedical Research Center	1988	3.5	Baton Rouge, LA	1	$1.1M	8
The Smith-Kettlewell Eye Research Institute	1963	4.2	San Francisco, CA	1	$50.0M	63

Rate Rutgers Cancer Institute of New Jersey's competitiveness in the market.

Rutgers Cancer Institute of New Jersey salaries vs competitors

Compare Rutgers Cancer Institute of New Jersey salaries vs competitors

Company	Average salary	Hourly salary	Salary score
Rutgers Cancer Institute of New Jersey	$81,624	$39.24	-

Compare Rutgers Cancer Institute of New Jersey job title salaries vs competitors

Company	Highest salary	Hourly salary
Rutgers Cancer Institute of New Jersey	$105,941	$50.93
One Laptop per Child	$109,567	$52.68
The Smith-Kettlewell Eye Research Institute	$99,175	$47.68
JMI Laboratories	$98,918	$47.56
New York State Education Department	$98,709	$47.46
Sandia National Labs	$97,429	$46.84
Roswell Park	$94,431	$45.40
Pennington Biomedical Research Center	$90,824	$43.67
Instituto Nacional De Salud Mental	$90,592	$43.55
IIT	$82,589	$39.71
NCWIT	$82,480	$39.65
Mathematical Sciences Research Institute - MSRI	$81,789	$39.32

Do you work at Rutgers Cancer Institute of New Jersey?

Is Rutgers Cancer Institute of New Jersey able to compete effectively with similar companies?

Rutgers Cancer Institute of New Jersey jobs

Rutgers Cancer Institute of New Jersey demographics vs competitors

Compare gender at Rutgers Cancer Institute of New Jersey vs competitors

Job title	Male	Female
Roswell Park	36%	64%
Rutgers Cancer Institute of New Jersey	37%	63%
NCWIT	40%	60%
Sandia National Labs	63%	37%

Male

Female

100%

75%

50%

25%

Sandia National Labs

NCWIT

Rutgers Cancer Institute of New Jersey

Roswell Park

25%

50%

75%

100%

Compare race at Rutgers Cancer Institute of New Jersey vs competitors

Company	White	Hispanic or Latino	Black or African American	Asian	Unknown	Diversity score
Rutgers Cancer Institute of New Jersey	51%	16%	11%	17%	5%	9.6
Roswell Park	56%	14%	13%	12%	4%	9.6
Sandia National Labs	51%	28%	6%	8%	7%	9.7
NCWIT	55%	7%	15%	21%	2%	9.0

Rutgers Cancer Institute of New Jersey and similar companies CEOs

CEOBio

Candace S. Johnson

Roswell Park

Candace S Johnson is a Board at OmniSeq and Professor:Pharmaceutical Science at University at Buffalo Foundation, Inc and is based in Buffalo, New York. She has experience at University of Pittsburgh - PITT and has worked as President and CEO at Roswell Park, Professor of Pharmacology and Medicine at University of Pittsburgh School of Medicine, and Deputy Director of Basic Research at UPMC Hillman Cancer Center. Candace attended The Ohio State University between 1974 and 1977.

Andrew Fuhrmeister

JMI Laboratories

John Brabyn

The Smith-Kettlewell Eye Research Institute

Arthur Holden

Pennington Biomedical Research Center

Core Specialties: Executive Management/Leadership, Entrepreneurship, Life Sciences, Human Genetics, and Medical Products. My ~ 45 year career in the healthcare technology/life sciences arena has involved the development and marketing of life saving (renal) medical products/related therapies and building three life science companies (Celsis International, First Genetic Trust and Illumina). My current passion involves founding and developing large-scale biomedical research consortia to exploit the potential of human genetics to better understand disease and drug response. I am currently leading my second international research consortium (i.e. The International Serious Adverse Events Consortium) and chairing the organization and launch of a third such effort (i.e. The Genomic Resources Consortium). I also lead PBRC Ltd. which advises and consults to private foundations, governments and companies on how to most effectively plan and execute large scale scientific research and data aggregation consortia. Finally, I also invest in and help to develop early stage life science/medical products companies.